Valneva SE (INRLF)
3.37
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Valneva Net Income (Quarterly) : -36.28M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.28M |
| March 31, 2026 | -37.52M |
| December 31, 2025 | -58.22M |
| September 30, 2025 | -51.83M |
| June 30, 2025 | -13.13M |
| March 31, 2025 | -9.716M |
| December 31, 2024 | -39.45M |
| September 30, 2024 | -10.15M |
| June 30, 2024 | -26.84M |
| March 31, 2024 | 63.94M |
| December 31, 2023 | -34.58M |
| September 30, 2023 | -37.23M |
| June 30, 2023 | -18.41M |
| March 31, 2023 | -19.45M |
| December 31, 2022 | -45.09M |
| September 30, 2022 | 72.90M |
| June 30, 2022 | -154.80M |
| March 31, 2022 | -29.21M |
| December 31, 2021 | 197.18M |
| September 30, 2021 | -188.05M |
| June 30, 2021 | -70.77M |
| March 31, 2021 | -33.37M |
| December 31, 2020 | -2.455M |
| September 30, 2020 | -42.89M |
| June 30, 2020 | -26.88M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.354M |
| December 31, 2019 | 0.7639M |
| September 30, 2019 | -0.0367M |
| June 30, 2019 | -8.151M |
| March 31, 2019 | 5.510M |
| December 31, 2018 | 7.436M |
| September 30, 2018 | -3.559M |
| June 30, 2018 | -1.967M |
| March 31, 2018 | 1.792M |
| December 31, 2017 | -4.330M |
| September 30, 2017 | -4.043M |
| June 30, 2017 | -2.979M |
| March 31, 2017 | -1.766M |
| December 31, 2016 | -2.928M |
| September 30, 2016 | -7.820M |
| June 30, 2016 | -38.87M |
| March 31, 2016 | -5.553M |
| December 31, 2015 | -0.8526M |
| September 30, 2015 | -5.74M |
| June 30, 2015 | -9.778M |
| March 31, 2015 | -5.642M |
| December 31, 2014 | -14.39M |
| September 30, 2014 | -3.402M |
| June 30, 2014 | -6.954M |
| March 31, 2014 | -9.745M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -- |
| Cellectis SA | -21.79M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 40.62M |
| Total Expenses (Quarterly) | 76.90M |
| EPS Diluted (Quarterly) | -0.1913 |
| Enterprise Value | 740.53M |
| Gross Profit Margin (Quarterly) | 4.58% |
| Profit Margin (Quarterly) | -89.31% |
| Earnings Yield | -31.06% |
| Normalized Earnings Yield | -31.07 |